$200M investment in algae-based omega-3 facility

Royal DSM and Evonik have announced plans to establish a joint venture producing omega-3 fatty acid products from natural marine algae for the animal nutrition and aquaculture markets. The innovation will enable the sustainable production of omega-3 fatty acids for animal nutrition without using fish oil from wild caught fish. DSM and Evonik plans to invest around US$ 200 million in the facility (US$100 million by each party over circa 2 years). The initial annual production capacity will meet roughly 15 % of the total current annual demand for EPA and DHA by the salmon aquaculture industry. The set-up of the joint venture, to be named Veramaris and headquartered in The Netherlands, will be finalized subject to regulatory approvals and other customary closing conditions.

Source: Nutrition Insight
Read more